|
化學名
Rosiglitazone |
[商品---廠商] Avandia-SmithKlein Beecham |
|
|
藥理分類 |
New Oral hypoglycemia agents,Insulin sensitizer,Glitazone, Thiazolidinedione |
|
|
治療分類 |
Hypoglycemic agents |
|
|
作用機轉 |
Increased Insulin sensitivity;Decreased Insulin resistance PPARs [Peroxisomal-proliferator-activated receptors] activation |
|
|
適應症 |
Type 2 Diabetes |
一般劑量 |
|
4mgQD; 2mgBID |
||
|
備註 |
•No hepatocellular injury as Troglitazone •FDA approve: 89.5.25. • • |
|
[89.6.29.]